MNK Stock Mallinckrodt plc - Complete Overview

Nyse / Pharmaceutical Products / Healthcare / MNK Stock

Mallinckrodt plc (MNK) price per share as of 13 Jul 2018
USD
Your sentiment
COLDTRENDOMETERHOT
Shares Outstanding 83.08M
Avg Daily Volume 3.12M
Market Cap 1.02B
Volatility 60.75% HIGH

MALLINCKRODT PLC (MNK) OVERVIEW

MNK stock is a pharmaceutical products company traded on Nyse. It is valued at 1.02B US dollars. There are 83.08M shares outstanding which Mallinckrodt plc issued to investors. Volatility of the stock is HIGH, and the daily volume is 60.75% stock on average. It brought investors a total return of -51.36% over the last 12 months. Mallinckrodt plc stock is relatively cheap. It's P/E ratio is below the market average.

Mallinckrodt plc (MNK) STOCK PRICE PERFORMANCE

MNK SHAREHOLDER'S RETURN

Earnings Per Share 17.66
Dividends Per Share 0.00
12 Months Price Performance Negative
Total Return Negative

MNK LATEST NEWS

Should Value Investors Consider Mallinckrodt (MNK) Stock?

Is Mallinckrodt (MNK) a great pick from the value investor's perspective right now? Read on to know more.

Mallinckrodt: The Cheapest Stock In Global Healthcare

Mallinckrodt is valued at a massive discount to its global comparable peers.At one point, shares traded below adjusted EBITDA and since then has rebounded over 40%.The company's controversial best sel

A Buvaya Failure Could Sting Insys

Clinical trial data may suggests INSY's Buvaya does not provide the efficacy and safety characteristics to garner FDA approval.A bet on INSY is likely a bet on its R&D pipeline. A miss on Buvaya could

Mallinckrodt: Appeals Court Rules Inomax Patent Invalid

A Federal Circuit Court ruled the majority of a patent for MNK's Inomax was invalid.It could pave the way for Praxair's generic Inomax.Inomax represents over 20% of MNK's revenue. Acthar and Inomax ar

Depomed Earnings Preview

DEPO reports quarterly earnings tomorrow.The company is distancing itself from Nucynta.It has an unproven business model and more than $600MM in debt at junk levels.If EBITDA turns lower then the rati

Here's Why Mallinckrodt PLC Rose as Much as 16.3% Today

The wild ride continues for investors.

Mallinckrodt plc (MNK) TECHNICAL INDICATORS

Name Value Action
RSI(14) 73.17 Strong buy
CMO(14) 46.33 Strong buy
ADX(14) 32.70 N/A
Williams %R -3.09 Sell

MNK STOCK VALUATION

MNK Industry Sector Market
Price to Earnings 0.70 58.99 86.82 29.24
Price to Book Value 0.16 4.24 4.45 3.48
Price to Sales 0.34 3.40 4.04 3.26
Return on Equity 29.60% 14.07% 14.08% 15.51%
Return on Assets 11.40% 6.17% 6.88% 5.81%
All values TTM (trailing twelve months). Source: Quandl.com

MNK FORUM DISCUSSIONS